Clik here to view.
Dr. Phil Skolnick Now Leads NIDA's Medications Development Efforts
April 01, 2010 Dr. Phil Skolnick has joined NIDA as director of the Division of Pharmacotherapies and Medical Consequences of Drug Abuse. Dr. Skolnick, who has extensive experience in corporate and...
View ArticleClik here to view.
Young Opioid Abusers Benefit From Extended Buprenorphine-Naloxone Treatment
Despite shorter addiction histories, youths' risk of relapse following detoxification resembles that of adults.April 01, 2010Lori Whitten, NIDA Notes Staff WriterOpioid-addicted youths benefit from...
View ArticleClik here to view.
Dr. Kathleen T. Brady Recognized
October 01, 2010The Medical University of South Carolina (MUSC) Board of Trustees bestowed the title of Distinguished University Professor upon Dr. Kathleen T. Brady on February 12, 2010. A leader in...
View ArticleIncentives Reduce Stimulant Abuse During Methadone Maintenance
April 01, 2007Methadone maintenance patients who earned chances to win prizes by providing stimulant-negative urine samples were twice as likely as those who received usual care to attain abstinence...
View ArticleAddiction and Co-Occurring Mental Disorders
February 01, 2007NIDA Director, Nora D. Volkow, M.D.As many as 6 in 10 substance abusers also have at least one other mental disorder. Research increasingly supports the benefit of studying and...
View ArticleNIDA Announces Avant-Garde Medication Development Awards
March 02, 2012Two scientists who are developing vaccines to treat addiction are the recipients of NIDA’s 2011 Avant-Garde Awards for Innovative Medication Development Research. Dr. Thomas Kosten of...
View ArticleClik here to view.
Vouchers Improve Mothers’ Smoking Abstinence and Newborns’ Weight
April 19, 2012Voucher payments for not smoking during pregnancy help women to stop using tobacco and boost the growth of their infants, according to an analysis of data from three controlled trials by...
View ArticleAlleviation of Posttraumatic Stress Disorder May Improve Addiction Treatment
April 19, 2012In a recent NIDA-funded study, women responded better to substance abuse treatment after their post-traumatic stress disorder (PTSD) symptoms improved, but reductions in substance abuse...
View ArticleClik here to view.
Women and Sex/Gender Differences Research Program
April 19, 2012Lori Whitten, NIDA Notes Staff WriterSince its inception, NIDA has sponsored research on issues related to women. Beginning with an early focus on the effects of drug use on pregnant...
View ArticleClik here to view.
Study Endorses Onsite HIV Testing Without Risk Reduction Counseling
April 29, 2013Results from NIDA’s Clinical Trials Network (CTN) affirm Centers for Disease Control and Prevention (CDC) recommendation that health care facilities serving high-risk populations offer...
View ArticleMedications That Treat Opioid Addiction Do Not Impair Liver Health
A trial of buprenorphine/naloxone (Bup/Nx) showed no evidence that the medicine was associated with liver damage. The drug gave results similar to those of methadone. The study data indicate that...
View ArticleDr. Kevin M. Gray Q & A: A Potential Medication for Marijuana Dependence
Dr. Kevin M. Gray discusses why it’s the perfect time for discovering new evidence-based treatments for marijuana dependence. In an accompanying podcast, he discusses a clinical trial that examines...
View ArticleDr. Kathleen T. Brady Recognized
Recognizes the 2010 Distinguished University Professor awardee, Dr. Kathleen T. Brady, who studies co-occurring substance abuse and mental health disorders and their treatment.
View ArticleIncentives Reduce Stimulant Abuse During Methadone Maintenance
Summarizes a study on the use of incentives to encourage abstinence among methadone maintenance patients in outpatient programs.
View ArticleAddiction and Co-Occurring Mental Disorders
Presents an overview of the research underway to investigate medication and behavioral therapies for co-occurring disorders.
View ArticleNIDA Announces Avant-Garde Medication Development Awards
Dr. Thomas Kosten of Baylor College of Medicine and Dr. Peter Burkhard of the University of Connecticut are the recipients of NIDA’s 2011 Avant-Garde Awards for Innovative Medication Development...
View ArticleVouchers Improve Mothers’ Smoking Abstinence and Newborns’ Weight
Pregnant women who received financial incentives to refrain from smoking during late pregnancy were more successful at remaining abstinent and less likely to have babies with low birth weight,...
View ArticleAlleviation of Post-traumatic Stress Disorder May Improve Addiction Treatment
Women with post-traumatic stress disorder (PTSD) who abused drugs responded better to substance abuse treatment after their PTSD symptoms improved, according to a recent study, which also found that...
View ArticleWomen and Sex/Gender Differences Research Program
NIDA’s Women and Sex/Gender Differences Research Program focuses on gender-specific addiction risk factors and treatment needs.
View ArticleStudy Endorses Onsite HIV Testing Without Risk Reduction Counseling
Patients were more likely to take a rapid HIV test when substance abuse treatment programs offered the test onsite rather than referred for offsite testing. Patients were equally likely to accept and...
View Article
